Today: 7 February 2026
Subscribe
Browse Category

NYSE:DDS News 16 December 2025 - 22 December 2025

Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

December 22, 2025 — Dillard’s, Inc. (NYSE: DDS) is back in the spotlight after a sharp selloff on Monday, adding fresh volatility to what’s been a remarkably strong year for one of America’s last major publicly traded department-store chains. Shares were last indicated around $610, down roughly 8% on the day after trading as high as the upper-$660s and as low as the low-$600s. The move lands at an awkward moment for investors: Dillard’s has paired steady operating performance with aggressive shareholder returns (including a $30 special dividend), but multiple research notes and data providers continue to flag valuation risk
22 December 2025
·····
Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s, Inc. (NYSE: DDS) is having one of those “only-in-markets” weeks: the stock recently tagged fresh highs, investors chased a $30 special dividend, and now the share price is digesting both the rally and the dividend mechanics. As of Tuesday, Dec. 16, 2025, DDS was trading around $645.61, down roughly 4.9% on the day, after opening near $678 and swinging between about $629 and $688. StockAnalysis That pullback follows a dramatic run into mid-December. Multiple market data services show DDS reaching an all-time high around $740–$742 on Dec. 11, 2025. TradingView+1 So what’s actually driving Dillard’s stock right now—and what
16 December 2025
····

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop